NDC 54868-4535-2 - LEVOXYL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54868-4535
- Requested NDC
- 54868-4535-2
- Package NDCs from labels
- 54868-4535-1, 54868-4535-2
- Manufacturer
- Physicians Total Care, Inc.
- Effective date
- 2013-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levoxyl ® (levothyroxine sodium tablets, USP) | Physicians Total Care, Inc. | 2013-08-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54868-4535-1 | 2019-09-24 | C162847 | 48780-1 | 9350213a-44f6-c013-e053-90daa90a1393 | Levoxyl ® (levothyroxine sodium tablets, USP) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54868-4535-1 | LEVOXYL | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54868-4535 | LEVOXYL (LEVOTHYROXINE SODIUM) TABLET [PHYSICIANS TOTAL CARE, INC.] | 5 | 1 package rows | 20130820_951c6e16-7251-42ed-ac19-d8367a6aee4f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54868-4535-0 | EA - Each | 54868-4535 | b4aef346-caf3-4da3-8d9d-1925e154fab5 | 1 | 2012-07-24 |
| 54868-4535-1 | EA - Each | 54868-4535 | e84f8d98-5131-4014-927f-495343aa1e72 | 1 | 2012-07-24 |
| 54868-4535-2 | EA - Each | 54868-4535 | 2dc70794-405b-4bee-8a56-d732a9fcb6e0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | ff7f5eff-4c90-4aa0-8915-704f92dea8aa | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | 8MDF5V39QO |
| Zegerid OTC | OMEPRAOLE, SODIUM BICARBONATE | Riley Consumer Care LLC | 8d00c19a-d86b-4a2f-8791-b320ad3ca781 | 2025-07-15 | Warnings | 8MDF5V39QO |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 412fc3f4-d9e0-49c5-b042-a6010aea7e5e | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| Leader Sinus Wash Saline Refill Packets | SODIUM BICARBONATE, SODIUM CHLORIDE | Cardinal Health, 110 dba LEADER | fb192a6d-318e-4d2b-89b6-42ac023e4fbd | 2025-07-09 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Westminster Pharmaceuticals, LLC | 9dcfc778-5fd6-4c68-8d37-a5385e374617 | 2025-07-08 | Warnings | 8MDF5V39QO |
| THYQUIDITY | LEVOTHYROXINE SODIUM | Oliva Therapeutics, LLC | 0c839877-50e4-455f-9b6c-462efb09cb96 | 2025-07-03 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 884f9fa1-58aa-4ff7-934f-106a0470e747 | 2025-07-03 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Schuessler Tissue Salts Calc Sulph Blood Cleanser 3 | CALCAREA SULPHURICA | Martin & Pleasance Pty Ltd | 0393cf03-4a68-4d01-bfb3-498e5ad626b1 | 2025-07-01 | Warnings | 4846Q921YM |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Anthea Pharma Private Limited | 0df8cf62-4b49-4ec4-aae4-c4a3e6d76549 | 2025-06-26 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Major Pharmaceuticals | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 2025-06-19 | Boxed warning, Warnings, Adverse reactions | 966248 966222 892246 966221 966224 966249 966220 966225 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | American Health Packaging | 38af4e36-b26b-485d-a6f3-7fbcf6072a0f | 2025-06-16 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 966224 966249 966220 966225 966253 9J765S329G |
| INFANT 4.2% SODIUM BICARBONATE | INFANT 4.2% SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | 78c25911-0042-664e-e053-2a91aa0a57a1 | 2025-06-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | f0680426-3581-400c-8ab5-5e6f18d0cabc | 2025-06-09 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b4654497-c986-4792-9b6b-0a791c7c205b | 2025-06-06 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 0e0ad9f1-1f52-48ce-a996-79ebe7ad53cd | 2025-06-06 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | 8MDF5V39QO |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 247f4d1d-6e65-4f81-a377-4dd88ae16dbb | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70dddaf0-f495-495f-95de-36e9efa2e373 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 91afb351-f067-49a2-bdf0-336ea209718d | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.